Intravenous Cyclophosphamide Treatment for Systemic Lupus Erythematosus with Severe Autonomic Disorders Confirmed by Head-Up Tilt Table Test: A Case Series.
Masataka UmedaHiroaki KawanoYushiro EndoAyuko TakataniTomohiro KogaKunihiro IchinoseHideki NakamuraAkihiro MukainoOsamu HiguchiShunya NakaneTakahiro MaedaAtsushi KawakamiPublished in: Modern rheumatology case reports (2021)
Autonomic disorders are common in patients with SLE, but the therapeutic strategy and methods for evaluating the effects of therapy have not been established. We describe the three cases of SLE patients who developed severe autonomic disorders as demonstrated by the head-up tilt table test (HUT). All three patients were treated by intensive immunosuppressive treatments including cyclophosphamide (IVCY); their HUT results all became negative. Our cases suggest that IVCY treatment can be a good therapeutic option for severe autonomic disorders in SLE patients. The HUT is a useful objective method for the diagnosis of and the evaluation of longitudinal therapeutic effects on autonomic disorders in SLE patients with orthostatic intolerance.
Keyphrases
- systemic lupus erythematosus
- heart rate variability
- end stage renal disease
- disease activity
- heart rate
- newly diagnosed
- ejection fraction
- chronic kidney disease
- high dose
- prognostic factors
- early onset
- rheumatoid arthritis
- peritoneal dialysis
- stem cells
- blood pressure
- drug induced
- cross sectional
- replacement therapy
- optic nerve